Yan, Zheyi <br/><br/>
CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner.  [electronic resource] 

 -  PloS one  2017 
 - e0178253 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0178253  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Biomarkers--metabolism<br/>Case-Control Studies<br/>Cells, Cultured<br/>Collagen--metabolism<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Retinopathy--diagnosis<br/>Endothelium, Vascular--cytology<br/>Female<br/>Glucose--adverse effects<br/>Humans<br/>Lipids--adverse effects<br/>Male<br/>Middle Aged<br/>Retinal Vessels--cytology<br/>Tumor Necrosis Factors--metabolism<br/>Vascular Cell Adhesion Molecule-1--metabolism